Belite Bio, Inc (BLTE) stock
BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
$169.96+14.02 (+8.99%)
Close on Nov 12, 2026Market cap $6.69BP/E –Yield –
Belite Bio EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was -$2.31. The highest annual figure on record is -$0.63 in fiscal 2022.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.31 | – |
| FY2024 | Dec 31, 2024 | -$1.18 | – |
| FY2023 | Dec 31, 2023 | -$1.19 | – |
| FY2022 | Dec 31, 2022 | -$0.63 | – |
| FY2021 | Dec 31, 2021 | -$1.01 | – |
| FY2020 | Dec 31, 2020 | -$0.65 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?